TRAF6 Activation and Its Role in Signaling Pathways
Author Information
Author(s): Matthew C. Walsh, Gregory K. Kim, Paul L. Maurizio, Elizabeth E. Molnar, Yongwon Choi
Primary Institution: University of Pennsylvania School of Medicine
Hypothesis
The study investigates the role of TRAF6 autoubiquitination in the activation of NFκB and MAPK pathways.
Conclusion
TRAF6 autoubiquitination is not required for the activation of NFκB and MAPK pathways in response to IL-1 and RANKL.
Supporting Evidence
- TRAF6 autoubiquitination was found to be dispensable for IL-1- or RANKL-dependent signaling.
- Lysine-deficient TRAF6 was capable of activating TAK1 and downstream signaling pathways.
- TRAF6-mediated ubiquitination of NEMO is required for optimal activation of NFκB.
Takeaway
TRAF6 is a protein that helps send signals in the body, and it can do its job even without a special type of self-modification called autoubiquitination.
Methodology
The study used genetic approaches to create TRAF6 mutants and assessed their ability to activate signaling pathways in various cell types.
Limitations
The study may not account for all potential lysine modifications on TRAF6 that could affect its function.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website